• Cassava Sciences is expected to announce -$0.42 per share.
• The company’s shares rose 20.78% in the past month.
• Investors hope Cassava’s earnings report is solid.

Cassava Sciences, Inc. (SAVA) finished at $30.44, down 1.17 percent from the previous day. This is behind the S&P 500’s 3.06 percent increase. Dow rose 2.68 percent, while tech-heavy Nasdaq fell 0.09 percent.

The company’s shares rose 20.78% in the past month, outperforming the Medical sector’s 2.37 percent loss and the S&P 500’s 4.31 percent loss.

Read More: Netflix is serious about gaming, adds popular indie title Into the Breach

Cassava Sciences analyst estimates changed.

This exemplifies how rapidly corporate fashions may shift in response to new information. It’s possible that favorable changes to estimates are a sign of a robust feeling of confidence.

Estimate modifications impact near-term stock prices, according to our analysis. Profitable investors use the Zacks Rank. This model includes estimate adjustments and a scoring system.

Read More: HCL Technologies launches Vancouver delivery center

Medical comprises Drugs. This industry ranks 146 out of 250+, or 43%.

To get a sector’s Zacks Industry Rank, we simply average the Zacks Ranks of the companies in that sector. Top industries are twice as dominant as bottom ones.

Zacks.com features stock-moving measures.

Zacks’ picks? The next 30 days’ 7 best stocks are now accessible. FREE REPORT